ARCHIVES

Roferon A Application Marred By Mission Data, Protocol, Compliance

This article is from The Cancer Letter archive.

Vol. 25 No. 36 | September 24, 1999

Download PDF Visit The Full Archive

Related Articles

Onco TCS Induces Responses In Relapsed Aggressive NHL

February 28, 2003

Clinical Cancer Research Battling Threats, Frei Says

May 15, 1981

ASCO, ASH Issue Guidelines On Use Of Epo For Anemia

October 25, 2002

NCI News: Communications Office Seeks Partners for Education Programs

October 11, 1996

FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate

October 8, 2010

Lilly Made False Claims About Ralozifene Reducing Breast Cancer risk, Judge Rules

July 30, 1999